No Detail Found!

Vascular ultrasound in the monitoring of vascular injury in patients after intravenous chemotherapy

Author(s)
Liling Lin Department of Ultrasound, West China Xiamen Hospital of Sichuan University,Xiamen, Fujian,China
Ling Li Department of Ultrasound, Zhangzhou Municipal Hospital of Fujian Province,Zhangzhou, Fujian,China
Jinglian Lin Department of Imaging, Zhangzhou Municipal Hospital of Fujian Province,Zhangzhou, Fujian,China
Abstract
This study investigated vascular injury incidence, symptoms, and changes in vascular wall thickness and blood flow in 140 chemotherapy patients. Vascular ultrasound and laboratory tests were conducted at 1 week, 1 month, and 3 months post-chemotherapy. Results showed that vascular injury incidence increased over time (12.9% at 1 week, 25.0% at 1 month, 34.3% at 3 months, P<0.05). Vascular wall thickness (IMT) thickened from 0.61±0.11 mm at baseline to 0.85±0.22 mm at 3 months (P<0.01) and vascular diameter increased from 2.34±0.22 mm to 2.55±0.33 mm at 3 months (P<0.01). Severe phlebitis incidence rose from 2.9% at 1 week to 7.1% at 3 months (P<0.01). Elevated CRP and D-dimer levels correlated with increased vascular wall thickness and thrombosis. Enhanced monitoring and personalized interventions are needed to reduce complications. Combining ultrasound and laboratory markers can improve assessment of chemotherapy-induced vascular injury.
Publication Details
Page(s) 1435-1441
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 38, Issue: 4, Year: 2025

Request the full text from PASTIC

Keywords
Chemotherapy, inflammation, Vascular injury, Phlebitis, venous access devices, abnormal blood flow, thrombotic markers, vascular wall thickness
References
Anastasiou M,Oikonomou E,Theofilis P,Kaski JC .2023 .Prolonged impact of anti-cancer therapy on endothelial function and arterial stiffness in breast cancer patients. Vasc Pharmacol, 152 : 107195.
Angjelova A,Jovanova E,Polizzi A,Pavlovic A .2024 .Impact of periodontitis on endothelial risk dysfunction and oxidative stress improvement in patients with cardiovascular disease. J Clin Med, 13(13) : 3781.
Aryal S,Park S,Park H,Kim J,Lee K .2023 .Clinical trials for oral, inhaled and intravenous drug delivery systems for lung cancer and emerging nanomedicinebased approaches. Int J Nanomedicine., 18 : 7865-7888.
Dent SF,Kikuchi R,Kondapalli L,Dent R .2020 .Optimizing cardiovascular health in patients with cancer: A practical review of risk assessment, monitoring, and prevention of cancer treatment-related cardiovascular toxicity. Am Soc Clin Oncol Educ Book, 40 : 501-515.
Gao C,Xu D,Sun C .2021 .Application of musculoskeletal ultrasound in real-time dynamic detection of Luschka joint hyperplasia of cervical vertebrae. J Med, 11(2) : 321-331.
Khanna AK,Khanna D AK .2023 .Uncommon ulcers of the extremities. , : 363-376.
Kumar V,Vellapandian C .2024 .Unraveling the nexus between ambient air pollutants and cardiovascular morbidity: Mechanistic insights and therapeutic horizons. , 16(9) : e68650.
Lopez-Garzon M,Cantarero-Villanueva I,LegerenAlvarez M,Fernandez-Lopez C .2022 .Prevention of chemotherapy-induced peripheral neuropathy with PRESIONA, a therapeutic exercise and blood flow restriction program: A randomized controlled study protocol. Phys Ther, 102(3) : pzab282.
Lustberg MB,Kuderer NM,Desai A,Lyman GH,Kushi LH .2023 .Mitigating long-term and delayed adverse events associated with cancer treatment: Implications for survivorship. Nat Rev Clin Oncol., 20(8) : 527-542.
McLaughlin M,Florida-James G,Ross M .2021 .Breast cancer chemotherapy vascular toxicity: A review of mediating mechanisms and exercise as a potential therapeutic. Vasc Biol, 3(1) : R106-R120.
Qu X,Zhou D,Lu J,Wang Y,Li Z Y .2023 .Cancer nanomedicine in preoperative therapeutics: nanotechnology-enabled neoadjuvant chemotherapy, radiotherapy, immunotherapy and phototherapy. , 24 : 136-152.
Saketkoo LA,Frech T,Varju C,Csikos G C .2021 .A comprehensive framework for navigating patient care in systemic sclerosis: A global response to the need for improving the practice of diagnostic and preventive strategies in SSc. Best Pract. Res. Clin. Rheumatol, 35(3) : 101707.
Stephenson E,McLaughlin M,Bray JW,Ross M .2024 .Nutrition modulation of cardiotoxicity in breast cancer: A scoping review. Nutrients., 16(21) : 3777.
Terwoord JD,Beyer AM,Gutterman DD .2022 .Endothelial dysfunction as a complication of anti-cancer therapy. Pharmacol Ther, 237 : 108116.
Tiwari A,Elgrably B,Saar G,Bhatia R G .2022 .Multiscale imaging of vascular pathologies in cardiovascular disease. Front Med, 8 : 754369.
Wei G,Wang Y,Yang G,Li H,Zhang J .2021 .Recent progress in nanomedicine for enhanced cancer chemotherapy. Theranostics., 11(13) : 6370-6391.
Wong ND,Budoff MJ,Ferdinand K,Blaha MJ K .2022 .Atherosclerotic cardiovascular disease risk assessment: An American Society for Preventive Cardiology clinical practice statement. Am. J. Prev. Cardiol., 10 : 100335.
Xu Y,Qi Y,Lu Z,Zhang L,Wang H L .2024 .Navigating precision: the crucial role of next-generation sequencing recurrence-risk assessment in tailoring adjuvant therapy for hormone receptor-positive, human epidermal growth factor receptor 2-negative early breast cancer. Cancer Biol Ther., 25(1) : 2405060.
Yang Y,Zhang X,Zhang R,Li H,Wang X .2024 .Current status and progress in arterial stiffness evaluation: A comprehensive review. Adv. Ultrasound Diagn. Ther., 8(4) : 172-182.
Zeng ZM,Mo N,Zeng J,Li H,Wang X .2022 .Advances in postoperative adjuvant therapy for primary liver cancer. World J Gastrointest Oncol., 14(9) : 1604-1612.
Zhang T,Liu N,Xu J,Wang Y,Li H Y .2023 .Flexible electronics for cardiovascular healthcare monitoring. Innovation., 4(5) : 100458.
0

Citations

0

Downloads

86

Views